Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Analyst Comment

Introduction to Gubra

By Claus ThestrupCEO, Sweden
Gubra

Introduction to Gubra - CEO Henrik Blou and CFO Kristian Borbos presenting the company.

Gubra consists of two business areas - CRO business that offers specialized pre-clinical contract research and development services for the pharmaceutical and biotechnology industry and the D&P business that offers discovery, design and development of peptidebased drug candidates with the aim of entering partnerships with pharmaceutical or biotechnology companies. The CRO business is generating topline and cashflow, The D&P is more a traditional Biotech business with milestones and cashburn. Good synergies between the two areas. Besides these two areas Gubra allocates 10% of pre-tax to Gubra Green with a true ESG footprint.

Listen to the presentation here: https://www.inderes.dk/videos/gubra-company-introduction 

Disclaimer:

HC Andersen Capital receives payment from Gubra for a DigitalIR/Corporate Visibility agreement.

Gubra is a pharmaceutical company. The company's operations are focused on the early stages of drug development. They primarily conduct research and development in the area of metabolic and fibrotic diseases. The company's product portfolio includes several brands and drugs, and the operations are conducted on a global level, with the largest presence in North America and the Nordic region. The headquarters are located in Hørsholm, Denmark.

Read more on company page
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.